Mutation and clinical characteristics of autosomal-dominant hereditary spastic paraplegias in China

Neurodegenerative Diseases

Volumn 14, Issue 4, 2014, Pages 176-183

  Luo, Yingying ^a   Chen, Chong ^a   Zhan, Zixiong ^a   Wang, Yinguang ^a   Du, Juan ^a   Hu, Zhaoting ^a   Liao, Xinxin ^a   Zhao, Guohua ^a   Wang, Junling ^a   Yan, Xinxiang ^a   Jiang, Hong ^a   Pan, Qian ^a   Xia, Kun ^a   Tang, Beisha ^a   Shen, Lu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ATL1 mutations; Gender difference; Hereditary spastic paraplegia; Neurodegenerative disease; SPAST mutations

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATL1 GENE; CHILD; CONTROLLED STUDY; EXON; FEMALE; GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; KIF5A GENE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATION RATE; NIPA1 GENE; NONSENSE MUTATION; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; REEP1 GENE; SEX DIFFERENCE; SLC33A1 GENE; SPAST GENE; SPG3A GENE; SPG4 GENE; CHINA; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY;

ADULT; CHINA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 84921435972     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000365513     Document Type: Article

References (41)

1. Harding AE: Classification of the hereditary ataxias and paraplegias. Lancet 1983; 1: 1151-1155.
2. Montenegro G, Rebelo AP, Connell J, Allison R, Babalini C, D'Aloia M, Montieri P, Schule R, Ishiura H, Price J, Strickland A, Gonzalez MA, Baumbach-Reardon L, Deconinck T, Huang J, Bernardi G, Vance JM, Rogers MT, Tsuji S, De Jonghe P, Pericak-Vance MA, Schols L, Orlacchio A, Reid E, Zuchner S: Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest 2012; 122: 538-544.
3. Finsterer J, Loscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G: Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 2012; 318: 1-18.
4. Novarino G, Fenstermaker AG, Zaki MS, et al: Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 2014; 343: 506-511.
5. Schule R, Schols L: Genetics of hereditary spastic paraplegias. Semin Neurol 2011; 31: 484-493.
6. McDermott CJ, Burness CE, Kirby J, Cox LE, Rao DG, Hewamadduma C, Sharrack B, Hadjivassiliou M, Chinnery PF, Dalton A, Shaw PJ: Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology 2006; 67: 45-51.
7. Svenson IK, Kloos MT, Gaskell PC, Nance MA, Garbern JY, Hisanaga S, Pericak-Vance MA, Ashley-Koch AE, Marchuk DA: Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics 2004; 5: 157-164.
8. Hewamadduma CA, Kirby J, Kershaw C, Martindale J, Dalton A, McDermott CJ, Shaw PJ: Hsp60 is a rare cause of hereditary spastic paraparesis, but may act as a genetic modifier. Neurology 2008; 70: 1717-1718.
9. Namekawa M, Ribai P, Nelson I, Forlani S, Fellmann F, Goizet C, Depienne C, Stevanin G, Ruberg M, Durr A, Brice A: SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology 2006; 66: 112-114.
10. Liu X, Tang J: Novel splice site mutation of SPG4 in a Chinese family with hereditary spastic paraplegia. Neurol Sci 2014, Epub ahead of print.
11. Feng Y, Ke X, Zhai M, Xin Q, Gong Y, Liu Q: Novel deletion of SPAST in a Chinese family with hereditary spastic paraplegia. Singapore Med J 2013; 54: 251-254.
12. Fei QZ, Tang WG, Rong TY, Tang HD, Liu JR, Guo ZL, Fu Y, Xiao Q, Wang XJ, He SB, Cao L, Chen SD: Two novel mutations in the spastin gene of Chinese patients with hereditary spastic paraplegia. Eur J Neurol 2011; 18: 1194-1196.
13. Qin W, Zhang T, Han J, Tang L, Li X, Feng G, Liu W, He L: A novel insertion mutation in spastin gene is the cause of spastic paraplegia in a Chinese family. J Neurol Sci 2003; 210: 35-39.
14. Chan KY, Ching CK, Mak CM, Lam CW, Chan AY: Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family. Hong Kong Med J 2009; 15: 304-307.
15. Li XH, Song C, Chen SQ, Zhou Y, Guo H, Zhou CL, Yang ZY, Liang YX, Wang YM: A SPG3A mutation with a novel foot phenotype of hereditary spastic paraplegia in a Chinese Han family. Chin Med J (Engl) 2007; 120: 834-837.
16. Ming L: SPG3A-hereditary spastin paraplegia with genetic anticipation and incomplete penetrance. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24: 15-18.
17. Chen S, Song C, Guo H, Xu P, Huang W, Zhou Y, Sun J, Li CX, Du Y, Li X, Liu Z, Geng D, Maxwell PH, Zhang C, Wang Y: Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families. Hum Mutat 2005; 25: 135-141.
18. Liu SG, Zhao JJ, Zhuang MY, Li FF, Zhang QJ, Huang SZ, Che FY, Lu de G, Liu SE, Teng JJ, Ma X: Clinical and genetic study of SPG6 mutation in a Chinese family with hereditary spastic paraplegia. J Neurol Sci 2008; 266: 109-114.
19. Lin P, Li J, Liu Q, Mao F, Li J, Qiu R, Hu H, Song Y, Yang Y, Gao G, Yan C, Yang W, Shao C, Gong Y: A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am J Hum Genet 2008; 83: 752-759.
20. Tang B, Zhao G, Xia K, Pan Q, Luo W, Shen L, Long Z, Dai H, Zi X, Jiang H: Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia. Arch Neurol 2004; 61: 49-55.
21. Zhao X, Alvarado D, Rainier S, Lemons R, Hedera P, Weber CH, Tukel T, Apak M, Heiman-Patterson T, Ming L, Bui M, Fink JK: Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 2001; 29: 326-331.
22. Durr A, Camuzat A, Colin E, Tallaksen C, Hannequin D, Coutinho P, Fontaine B, Rossi A, Gil R, Rousselle C, Ruberg M, Stevanin G, Brice A: Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 2004; 61: 1867-1872.
23. Sauter SM, Engel W, Neumann LM, Kunze J, Neesen J: Novel mutations in the atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus. Hum Mutat 2004; 23: 98.
24. Wilkinson PA, Hart PE, Patel H, Warner TT, Crosby AH: SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J Neurol Sci 2003; 216: 43-45.
25. Orlacchio A, Montieri P, Babalini C, Gaudiello F, Bernardi G, Kawarai T: Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation. J Neurol 2011; 258: 1361-1363.
26. Du J, Hu YC, Tang BS, Chen C, Luo YY, Zhan ZX, Zhao GH, Jiang H, Xia K, Shen L: Expansion of the phenotypic spectrum of SPG6 caused by mutation in NIPA1. Clin Neurol Neurosurg 2011; 113: 480-482.
27. Ivanova N, Claeys KG, Deconinck T, Litvinenko I, Jordanova A, Auer-Grumbach M, Haberlova J, Lofgren A, Smeyers G, Nelis E, Mercelis R, Plecko B, Priller J, Zamecnik J, Ceulemans B, Erichsen AK, Bjorck E, Nicholson G, Sereda MW, Seeman P, Kremensky I, Mitev V, De Jonghe P: Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol 2007; 64: 706-713.
28. Beetz C, Nygren AO, Schickel J, Auer-Grumbach M, Burk K, Heide G, Kassubek J, Klimpe S, Klopstock T, Kreuz F, Otto S, Schule R, Schols L, Sperfeld AD, Witte OW, Deufel T: High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 2006; 67: 1926-1930.
29. Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribai P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A: Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet 2007; 44: 281-284.
30. Sulek A, Elert E, Rajkiewicz M, Zdzienicka E, Stepniak I, Krysa W, Zaremba J: Screening for the hereditary spastic paraplaegias SPG4 and SPG3A with the multiplex ligation-dependent probe amplification technique in a large population of affected individuals. Neurol Sci 2013; 34: 239-242.
31. Bross P, Li Z, Hansen J, Hansen JJ, Nielsen MN, Corydon TJ, Georgopoulos C, Ang D, Lundemose JB, Niezen-Koning K, Eiberg H, Yang H, Kolvraa S, Bolund L, Gregersen N: Single-nucleotide variations in the genes encoding the mitochondrial HSP60/HSP10 chaperone system and their disease-causing potential. J Hum Genet 2007; 52: 56-65.
32. Fonknechten N, Mavel D, Byrne P, Davoine CS, Cruaud C, Bonsch D, Samson D, Coutinho P, Hutchinson M, McMonagle P, Burgunder JM, Tartaglione A, Heinzlef O, Feki I, Deufel T, Parfrey N, Brice A, Fontaine B, Prud'homme JF, Weissenbach J, Durr A, Hazan J: Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 2000; 9: 637-644.
33. de Bot ST, van den Elzen RT, Mensenkamp AR, Schelhaas HJ, Willemsen MA, Knoers NV, Kremer HP, van de Warrenburg BP, Scheffer H: Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations. J Neurol Neurosurg Psychiatry 2010; 81: 1073-1078.
34. Mitne-Neto M, Kok F, Beetz C, Pessoa A, Bueno C, Graciani Z, Martyn M, Monteiro CB, Mitne G, Hubert P, Nygren AO, Valadares M, Cerqueira AM, Starling A, Deufel T, Zatz M: A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigree. Eur J Hum Genet 2007; 15: 1276-1279.
35. Santorelli FM, Patrono C, Fortini D, Tessa A, Comanducci G, Bertini E, Pierallini A, Amabile GA, Casali C: Intrafamilial variability in hereditary spastic paraplegia associated with an SPG4 gene mutation. Neurology 2000; 55: 702-705.
36. Higgins JJ, Loveless JM, Goswami S, Nee LE, Cozzo C, De Biase A, Rosen DR: An atypical intronic deletion widens the spectrum of mutations in hereditary spastic paraplegia. Neurology 2001; 56: 1482-1485.
37. Orlacchio A, Kawarai T, Gaudiello F, Totaro A, Schillaci O, Stefani A, Floris R, St George-Hyslop PH, Sorbi S, Bernardi G: Clinical and genetic study of a large SPG4 Italian family. Mov Disord 2005; 20: 1055-1059.
38. Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF: Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res 2004; 14(suppl A): S18-S33.
39. Hu R, Sun H, Zhang Q, Chen J, Wu N, Meng H, Cui G, Hu S, Li F, Lin J, Wan Q, Feng H: G-protein coupled estrogen receptor 1 mediated estrogenic neuroprotection against spinal cord injury. Crit Care Med 2012; 40: 3230-3237.
40. D'Amico A, Tessa A, Sabino A, Bertini E, Santorelli FM, Servidei S: Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene. Neurology 2004; 62: 2138-2139.
41. Varga RE, Schule R, Fadel H, Valenzuela I, Speziani F, Gonzalez M, Rudenskaia G, Nurnberg G, Thiele H, Altmuller J, Alvarez V, Gamez J, Garbern JY, Nurnberg P, Zuchner S, Beetz C: Do not trust the pedigree: reduced and sex-dependent penetrance at a novel mutation hotspot in ATL1 blurs autosomal dominant inheritance of spastic paraplegia. Hum Mutat 2013; 34: 860-863